Advantage Alpha Capital Partners’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-53,609
Closed -$2.09M – 173
2024
Q3
$2.09M Buy
53,609
+8,956
+20% +$357K 0.48% 81
2024
Q2
$1.95M Sell
44,653
-31,108
-41% -$1.5M 0.43% 79
2024
Q1
$3.61M Buy
+75,761
New +$3.41M 0.68% 68
2023
Q4
– Sell
-49,058
Closed -$2.34M – 161
2023
Q3
$2.34M Sell
49,058
-33,061
-40% -$1.8M 0.49% 82
2023
Q2
$4.78M Buy
82,119
+30,510
+59% +$1.83M 0.96% 50
2023
Q1
$3.69M Buy
51,609
+8,735
+20% +$693K 0.77% 61
2022
Q4
$3.02M Sell
42,874
-12,826
-23% -$904K 0.61% 61
2022
Q3
$3.38M Sell
55,700
-41,738
-43% -$2.8M 0.62% 59
2022
Q2
$6.15M Buy
97,438
+11,096
+13% +$723K 1.06% 50
2022
Q1
$5.53M Buy
86,342
+24,877
+40% +$1.66M 0.83% 62
2021
Q4
$4.41M Sell
61,465
-6,661
-10% -$507K 0.63% 77
2021
Q3
$4.86M Buy
68,126
+5,268
+8% +$415K 0.89% 50
2021
Q2
$5.11M Buy
62,858
+13,644
+28% +$1.1M 0.99% 43
2021
Q1
$3.72M Sell
49,214
-913
-2% -$66.5K 0.78% 69
2020
Q4
$3.8M Sell
50,127
-15,519
-24% -$1.01M 0.83% 59
2020
Q3
$3.25M Sell
65,646
-12,619
-16% -$712K 0.75% 69
2020
Q2
$4.11M Buy
78,265
+8,416
+12% +$399K 0.96% 48
2020
Q1
$2.46M Buy
69,849
+21,957
+46% +$1.28M 0.88% 56
2019
Q4
$4.18M Buy
+47,892
New +$4.19M 1.13% 33

Other funds holding NGVT

Advantage Alpha Capital Partners's NGVT Position: Q4 2024 in Review

Advantage Alpha Capital Partners sold out of Ingevity (NGVT) in Q4 2024, closing a stake of 53,609 shares — an estimated $2.09M sold.

Advantage Alpha Capital Partners first reported a position in NGVT in Q4 2019 and held it in 19 quarters. The position peaked at $6.15M in Q2 2022. 257 funds tracked by Wall St. Rank hold NGVT as of Q4 2024.

  • Advantage Alpha Capital Partners reported no remaining Ingevity position as of Q4 2024 after selling out during the quarter.
  • Advantage Alpha Capital Partners sold 53,609 Ingevity shares in Q4 2024, an estimated $2.09M.
  • Advantage Alpha Capital Partners first reported a position in Ingevity in Q4 2019 and held it in 19 quarters.
  • Advantage Alpha Capital Partners's Ingevity position peaked at $6.15M in Q2 2022.
  • 257 funds tracked by Wall St. Rank held Ingevity as of Q4 2024.

Based on Advantage Alpha Capital Partners's 13F filing for Q4 2024, filed 11 Feb 2025.